Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2101133 | 注射用SHR-A1912 | SHR-A1912 | Lyophilized | Biological Products(1) | New Drug Application | 2021-06-15 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
CXSB2500009 | 注射用SHR-A1912 | SHR-A1912 | Lyophilized | Biological Products(1) | Supplementary Application | 2025-01-10 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
CXSL2300453 | 注射用SHR-A1912 | SHR-A1912 | Lyophilized | Biological Products(1) | New Drug Application | 2023-07-06 | Shanghai Hengrui Pharmaceutical Co Ltd | view |